Be skeptical of anti-aging supplement marketing
The ITP uses three independent labs with genetically diverse mice, centrally prepared food, and identical protocols to reduce false positives. Since 2004, it has tested compounds like resveratrol, NR, fisetin, fish oil, and more—most have shown no lifespan benefit. The pattern of hype follows a predictable cycle: a single mouse study sparks excitement, companies launch products, and later ITP replication fails, but the products remain on sale. The resveratrol case is emblematic: a Nature paper led to a $720 million acquisition by GSK, but the mechanism was later traced to a lab artifact, a clinical trial was halted over kidney damage, and the subsidiary was shut down. Yet resveratrol supplements are still sold. This protocol encourages consumers to wait for ITP replication before trusting any anti-aging supplement claim.
The ITP's multi-site design controls for lab-specific environmental variables and genetic homogeneity that can produce chance findings. By requiring consistent results across Jackson Lab, Michigan, and Texas, it ensures that a lifespan effect is robust and not an artifact of a single facility or mouse strain.
Brad Stanfield applies this skepticism himself: 'I'd encourage you to be incredibly skeptical of any company trying to sell you a longevity or anti-aging supplement.'
The pattern is always the same. We have promising mouse studies, press releases, product launches, years of sales, and then quietly follow-up data comes in, but by then nobody's paying attention.